|
2023
|
Invention
|
Polymorphic form of tg02 for treating cancer.
The present disclosure provides crystalline polymo... |
|
|
Invention
|
Treatment of cancer with tg02.
The present disclosure provides therapeutic methods of treating a... |
|
|
Invention
|
Combination therapy for cancers with braf mutation.
The present disclosure provides a combinatio... |
|
2022
|
Invention
|
Methods and compositions for treating ewing family of tumors.
Provided is the use of YM155 monob... |
|
2021
|
Invention
|
Combination therapies and biomarkers for treating cancer.
Provided are methods of using an anti-... |
|
|
Invention
|
Combination therapies and biomarkers for treating b-cell lymphomas.
Provided are combination the... |
|
2020
|
Invention
|
Combination therapy for cancers with kras mutation.
It relates to a combination therapy for trea... |
|
|
Invention
|
Combination therapy for cancers with kras mutation.
Provided is a combination therapy for treati... |
|
|
Invention
|
Combination therapy for cancers with kras mutation. It relates to a combination therapy for treat... |
|
|
Invention
|
Combination therapy for cancers with kras mutation. Provided is a combination therapy for treatin... |
|
|
Invention
|
Polymorphic form of tg02 for treating cancer. The present disclosure provides crystalline polymor... |
|
2019
|
Invention
|
Combination therapy for cancers with braf mutation. The present disclosure provides a combination... |
|
2018
|
Invention
|
Polymorphic form of tg02. The present disclosure provides crystalline polymorphic forms of TG02 f... |
|
|
Invention
|
Combination therapies for treating cancers. Provided are combination therapies and related compos... |
|
2017
|
Invention
|
Treatment of cancer with tg02. The present disclosure provides therapeutic methods of treating a ... |
|
2011
|
Invention
|
Solid state forms of macrocyclic kinase inhibitors. Provided herein are salt forms of macrocyclic... |
